SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-07-067628
Filing Date
2007-09-07
Accepted
2007-09-07 14:59:02
Documents
5
Period of Report
2007-09-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a07-23335_18k.htm 8-K 25603
2 EX-99.1 a07-23335_1ex99d1.htm EX-99.1 15582
3 EX-99.2 a07-23335_1ex99d2.htm EX-99.2 13326
4 GRAPHIC g233351moi001.jpg GRAPHIC 2893
5 GRAPHIC g233351mmi001.jpg GRAPHIC 2893
  Complete submission text file 0001104659-07-067628.txt   64425
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114 2062817001
PONIARD PHARMACEUTICALS, INC. (Filer) CIK: 0000755806 (see all company filings)

IRS No.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16614 | Film No.: 071105729
SIC: 2835 In Vitro & In Vivo Diagnostic Substances